Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	84441
Country	China

Received	2023-03-28 09:38
Peer-Review Started	2023-03-28 09:39
To Make the First Decision
Return for Revision	2023-04-10 02:47
Revised	2023-05-02 14:10
Second Decision	2023-06-13 03:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-06-13 08:08
Articles in Press	2023-06-13 08:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-07-03 08:31
Publish the Manuscript Online	2023-07-12 11:13

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers
Manuscript Source	Unsolicited Manuscript
All Author List	Tian-Wei Zhang, Peng Zhang, Dong Nie, Xin-Yu Che, Tian-Tai Fu and Yan Zhang
ORCID	Author(s) ORCID Number Yan Zhang http://orcid.org/0009-0009-2897-3975
Funding Agency and Grant Number
Corresponding Author	Yan Zhang, MS, Doctor, Department of Hematology and Radiotherapy, Zibo 148 Hospital, No. 20 Zhanbei Road, Zhoucun District, Zibo 255300, Shandong Province, China. zhangyan100862023@163.com
Key Words	Thalidomide; Concurrent chemoradiotherapy; Esophageal carcinoma; Therapeutic effect; Serum tumor markers
Core Tip	Esophageal carcinoma (EC) is a common and fatal digestive tract tumor, and the current therapeutic methods such as surgical resection, radiotherapy and chemotherapy have limited effects and are accompanied by relatively serious adverse events. Therefore, clinical exploration of new treatment strategies for esophageal cancer should be continued to optimize the management of EC patients.
Publish Date	2023-07-12 11:13
Citation	Zhang TW, Zhang P, Nie D, Che XY, Fu TT, Zhang Y. Efficacy of concurrent chemoradiotherapy with thalidomide and S-1 for esophageal carcinoma and its influence on serum tumor markers. World J Gastrointest Oncol 2023; 15(7): 1262-1270
URL	https://www.wjgnet.com/1948-5204/full/v15/i7/1262.htm
DOI	https://dx.doi.org/10.4251/wjgo.v15.i7.1262

Full Article (PDF)	WJGO-15-1262-with-cover.pdf
Full Article (Word)	WJGO-15-1262.docx
Manuscript File	84441_Auto_Edited-JLW.docx
Answering Reviewers	84441-Answering reviewers.pdf
Audio Core Tip	84441-Audio core tip.mp3
Biostatistics Review Certificate	84441-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	84441-Conflict-of-interest statement.pdf
Copyright License Agreement	84441-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	84441-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	84441-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	84441-Language certificate.pdf
Peer-review Report	84441-Peer-review(s).pdf
Scientific Misconduct Check	84441-Bing_Wang JL-2.png
Scientific Misconduct Check	84441-CrossCheck.png
Scientific Editor Work List	84441-Scientific editor work list.pdf